Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Herpes zoster
ADR ID BADD_A02064
ADR Hierarchy
11      Infections and infestations
11.05      Viral infectious disorders
11.05.02      Herpes viral infections
11.05.02.003      Herpes zoster
23      Skin and subcutaneous tissue disorders
23.09      Skin and subcutaneous tissue infections and infestations
23.09.03      Skin and subcutaneous tissue viral infections
23.09.03.002      Herpes zoster
Description An acute infectious, usually self-limited, disease believed to represent activation of latent varicella-zoster virus (HERPESVIRUS 3, HUMAN) in those who have been rendered partially immune after a previous attack of CHICKENPOX. It involves the SENSORY GANGLIA and their areas of innervation and is characterized by severe neuralgic pain along the distribution of the affected nerve and crops of clustered vesicles over the area. (From Dorland, 27th ed) [MeSH]
MedDRA Code 10019974
MeSH ID D006562; D006562; D006562
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE)
Synonym
Herpes zoster | Herpes zoster (excl ophthalmic) | Herpes zoster C2 | Herpes zoster dermatitis | Herpes zoster NOS | Herpes zoster with other specified complication | Herpes zoster with other specified complications | Herpes zoster with unspecified complication | Herpes zoster without mention of complication | Shingles | Zona | Herpes Zoster | Zoster
ADR Related Proteins
Protein Name UniProt AC TTD Target ID
Not AvailableNot AvailableNot Available
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00012Abatacept--
BADD_D00014Abiraterone0.010297%
BADD_D00039Acyclovir0.000626%
BADD_D00041Adalimumab--
BADD_D00047Afatinib0.001598%
BADD_D00066Alendronic acid0.005052%
BADD_D00076Allopurinol--
BADD_D00100Ambrisentan--
BADD_D00151Apixaban--
BADD_D00156Apremilast--
BADD_D00159Arformoterol--
BADD_D00160Arformoterol tartrate--
BADD_D00168Arsenic--
BADD_D00169Arsenic trioxide0.000533%
BADD_D00178Atenolol--
BADD_D00180Atomoxetine0.000992%
BADD_D00193Axitinib--
BADD_D00194Azacitidine--
BADD_D00195Azathioprine0.007898%
BADD_D00214Basiliximab--
BADD_D00230Bendamustine0.001332%
BADD_D00231Bendamustine hydrochloride--
BADD_D00269Bexarotene--
BADD_D00271Bicalutamide--
BADD_D00274Bimatoprost--
BADD_D00284Bortezomib0.009058%
BADD_D00285Bosentan0.003577%
BADD_D00286Bosutinib--
BADD_D00290Botulinum toxin type a--
BADD_D00306Budesonide0.000406%
The 1th Page    1 2 3 4 5    Next   Last    Total 10 Pages